Cellular Analytics is using a new technology for liquid biopsy - CytoFind™ - that reports on the phenotypic properties of tumors and metastatic disease.

​

By providing information on the molecular features of a tumor in real-time, patients can be matched with the most effective and compatible therapy for improved treatment outcomes.